Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Monoclonal antibodies are a type of drug classified as "immunotherapy" ... Similar to terrorist cells living and working in plain sight, cancer cells live ...
The finding is a boost to cancer immunotherapy, a treatment strategy that unleashes the immune system to seek out and destroy cancer. In a new ...
Risks highest for those treated before age 25 and with mediastinal radiotherapy or anthracyclines Read more
Overall rates low despite greater use in younger patients and those with a high recurrence risk. Read more
"You have your own different immune system which is going to shape what your cancer turns into so I think the personalized approach is going to be ...
Researchers from the study speculate that introducing infants to solid food past 6 months of age could have an adverse effect on their immune system.
The addition of pembrolizumab is aimed at activating the body's own immune system to improve the results that otherwise might be achieved from ...
The study will be conducted at the Memorial Sloan Kettering Cancer Center in New York led ... "Advances in immune-based therapeutic strategies have demonstrated the significant potential of harnessing the immune system as an ...
The FDA granted MM-398 a fast track designation in November 2014 for patients with metastatic pancreatic cancer, allowing the developers of the ...
PharmaEngine Announces Merrimack Completed MM-398 (PEP02) New Drug Application ... - Yahoo Finance UK
“The factors we found that increase risk of pancreatic cancer now allow us to separate patients as either low or high risk. High-risk patients can then be ...
The agenda of the pre-clinical study is to arrive at a conclusion on whether Pharmacyte Biotech Inc (OTCMKTS:PMCB)'s pancreatic cancer treatment ...
That means one day, physicians might soon be able to find cancer ... “A cancer like pancreatic cancer, although it's almost uniformly lethal, is not ...
Magnetic resonance imaging screening is an effective tool for detecting early pancreatic cancer among people with high risk of developing the ...
"Our submission to the EMA included survival data from our single arm gemcitabine/REOLYSIN® (REO 017) clinical study in pancreatic cancer ...
In the phase III open-label NAPOLI-1 trial, 417 patients with gemcitabine-refractory metastatic pancreatic cancer were randomized to MM-398 ...
Try these cancer-fighting vegetables ... have uncovered evidence it may be effective against melanoma, esophageal cancer and pancreatic cancer.
WASHINGTON — Two powerhouses of cancer support — the American Association for Cancer Research (AACR) and the Pancreatic Cancer Action ...
Medical Xpress
Cancer is a complex disease, and without access to detailed medical ... He was widely reported to have pancreatic cancer, but in fact he had a very ...
The ONS said it should be noted that the particularly wide disparity with regard to bladder cancer is likely to be due to changes in classification.
Science Daily Cancer News
New proton therapy technique brings hope of more effective treatment for tumors without causing collateral damage
Researchers have succeeded in making a model of breathing movement that allows for the precise measurement of narrow beams to a dummy tumor in the lung by simulating the motion and physical properties of the chest anatomy in a model, thereby taking a large step towards maximizing the targeting of treatment in mobile organs.
Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years
Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later.
Among patients with cancer, rates of health insurance coverage vary by patient demographics and by cancer type, a new analysis has found. The researchers found that younger, non-white, unmarried patients residing in counties with higher levels of poverty and in rural areas were less likely to have insurance. Moreover, males were less likely to have insurance than females, and people residing in Southern states were less likely to have insurance than people residing in other areas of the country. Also, there was large variation in insurance rates by cancer type, with the highest uninsured rates in testicular, stomach, and cervical cancers, and the lowest uninsured rates in thyroid, prostate, and breast cancers.
In certain types of cancer, nerves and cancer cells enter an often lethal and intricate waltz where cancer cells and nerves move toward one another and eventually engage in such a way that the cancer cells enter the nerves.
Scientists have mapped genes affected by phytonutrients in soy, and have found that minimally processed soy flour suppresses breast cancer, while purified isoflavones stimulate genes that accelerate tumor growth, raising questions about soy supplements' safety for postmenopausal women.
Women diagnosed with breast cancer who previously breastfed their babies had a 30 percent overall decreased risk of the disease recurring, according to a new Kaiser Permanente study published in the Journal of the National Cancer Institute. In addition, researchers found that the protective effect of breastfeeding was more pronounced for tumors of particular genetic subtypes, including the most commonly diagnosed of all breast cancers.
New studies examine the significant risk of life-threatening blood clots in post-surgical lung cancer patients
Lung cancer surgery patients are at higher risk of developing venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE), than previously thought, with elevated risks of complications or death. When thromboemboli occur, they may be asymptomatic or attributed to post-surgical pain or complications, and may reflect both the lung cancer itself as well as compromised lung function after surgery. These incidents may also be ascribed to an inconsistent approach to prevention that currently exists among thoracic surgeons and hematologists who care for these patients, researchers warn.
Scientists have found dramatic effects on risk factors for colon cancer when American and African volunteers swapped diets for just two weeks.
Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein. However, not all of these patients respond to the drug, and many who do respond eventually acquire resistance.
Tambahkan Komentar